Etofibrate

This MedLibrary.org supplementary page on Etofibrate is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Etofibrate
Systematic (IUPAC) name
2-{[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy}ethyl nicotinate
Identifiers
CAS number 31637-97-5
ATC code C10AB09
PubChem 65777
Chemical data
Formula C18H18ClNO5 
Mol. mass 363.792 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism Hydrolyzed to clofibric acid and niacin
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Etofibrate is a fibrate. It is a combination of clofibrate and niacin, linked together by an ester bond. In the body, clofibrate and niacin separate and are released gradually, in a manner similar to controlled-release formulations.[1]

References

  1. ^ Sposito AC, Mansur AP, Maranhão RC, Rodrigues-Sobrinho CR, Coelho OR, Ramires JA (2001). "Etofibrate but not controlled-release niacin decreases LDL cholesterol and lipoprotein (a) in type IIb dyslipidemic subjects". Braz J Med Biol Res 34 (2): 177–82. PMID 11175492.  Free full text


Wikipedia content modification information:

  • This page was last modified on 15 August 2007, at 16:02.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Etofibrate".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.